M&A Deal Summary |
|
|---|---|
| Date | 2010-01-14 |
| Target | Meikang Biotech Co. |
| Sector | Medical Products |
| Buyer(s) | bioMerieux |
| Deal Type | Add-on Acquisition |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1963 |
| Sector | Life Science |
| Employees | 14,147 |
| Revenue | 4.0B EUR (2024) |
bioMerieux is a provider in the field of in vitro diagnostic solutions (reagents, instruments, software) that determine the source of disease and contamination to improve patient health and ensure consumer safety. Its products are used for diagnosing infectious diseases and providing high medical value results for cancer screening, monitoring, and cardiovascular emergencies. bioMerieux was founded in 1963 and is based in Marcy-l'Étoile, France.
| DEAL STATS | # |
|---|---|
| Overall | 11 of 21 |
| Sector: Medical Products M&A | 4 of 9 |
| Type: Add-on Acquisition M&A Deals | 8 of 17 |
| Country: China M&A | 1 of 3 |
| Year: 2010 M&A | 1 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2008-12-08 |
PML Microbiologicals
Wilsonville, Oregon, United States PML Microbiologicals, Inc. is a provider of culture media and microbiological products in North America for both clinical and industrial applications. |
Buy | $30M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2010-02-25 |
Shanghai Zenka Biotechnology
Shanghai, China Shanghai Zenka Biotechnology is a specialist in culture media. |
Buy | - |
